ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

Gossamer Bio, Inc. Complete list of announcements declared & dividend announcements by Gossamer Bio, Inc. GOSS

Gossamer Bio, Inc. GOSS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Gossamer Bio, Inc. GOSS

HC Wainwright & Co. Reiterates Gossamer Bio (GOSS) Buy Recommendation
Fintel reports that on May 11, 2023, HC Wainwright & Co. reiterated coverage of Gossamer Bio (NASDAQ:GOSS) with a Buy recommendation.
Announcement as on 11 May 2023

Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug
Shares of Gossamer Bio Inc. plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase 2 clinical trial. Though Gossamer said the drug, seralutinib, met th
Announcement as on 06 December 2022

Why Gossamer Bio Stock Falling In Pre-market?
(RTTNews) - Gossamer Bio, Inc. (GOSS) reported topline results from its phase 2 SHIFT-UC clinical trial studying GB004 in patients with mild-to-moderate active ulcerative colitis. The company said neither statistically significant nor clinically meaningful
Announcement as on 25 April 2022

Gossamer Bio Appoints CFO Bryan Giraudo To Addl. Role Of COO - Quick Facts
(RTTNews) - Biopharmaceutical company Gossamer Bio, Inc. (GOSS) announced Tuesday that Bryan Giraudo has been appointed Chief Operating Officer, in addition to his continued role as Chief Financial Officer. Giraudo joined Gossamer in May 2018 as its Chief
Announcement as on 21 September 2021

Announcements by Gossamer Bio, Inc. first page |

GOSS Gossamer Bio, Inc. current price & indicator signals

Moving Averages for Gossamer Bio, Inc.

  • 5Day Average: 3.24
  • 12Day Average: 3.22
  • 20Day Average: 3
  • 50Day Average: 2.65
  • 100Day Average: 2.51
  • 150Day Average: 2.08
  • 200Day Average: 1.83

GOSS Indicators & signals

Indicator MACD (12,26,9)

3.17, 2.96, 0.19
Indicator MACD is in positive zone

Indicator ADX (14)

0, 30.43, 30.43
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GOSS Gossamer Bio, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 3.33 3.22 to 3.45 0.3% 0.6 times
04 Thu Dec 2025 3.32 3.30 to 3.44 -2.92% 0.64 times
03 Wed Dec 2025 3.42 3.01 to 3.45 14.38% 1.74 times
02 Tue Dec 2025 2.99 2.97 to 3.15 -4.78% 1.36 times
01 Mon Dec 2025 3.14 3.11 to 3.31 -5.99% 1.33 times
28 Fri Nov 2025 3.34 3.25 to 3.40 -0.3% 0.42 times
26 Wed Nov 2025 3.35 3.08 to 3.37 2.45% 0.51 times
25 Tue Nov 2025 3.27 3.19 to 3.34 2.83% 0.88 times
24 Mon Nov 2025 3.18 2.99 to 3.23 3.92% 1.01 times
21 Fri Nov 2025 3.06 2.93 to 3.17 -1.61% 1.01 times
20 Thu Nov 2025 3.11 3.05 to 3.28 -0.96% 1.09 times
19 Wed Nov 2025 3.14 3.02 to 3.20 3.63% 1.13 times

Videos related to: GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

 

Back to top